An Emerging Maestro of Immune Regulation: How DOT1L Orchestrates the Harmonies of the Immune System

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Jul 4

PMID 38962004

Authors

Liam Kealy

Jessica Runting

Daniel Thiele

Sebastian Scheer

Affiliations

Soon will be listed here.

Abstract

The immune system comprises a complex yet tightly regulated network of cells and molecules that play a critical role in protecting the body from infection and disease. The activity and development of each immune cell is regulated in a myriad of ways including through the cytokine milieu, the availability of key receptors, via tailored intracellular signalling cascades, dedicated transcription factors and even by directly modulating gene accessibility and expression; the latter is more commonly known as epigenetic regulation. In recent years, epigenetic regulators have begun to emerge as key players involved in modulating the immune system. Among these, the lysine methyltransferase DOT1L has gained significant attention for its involvement in orchestrating immune cell formation and function. In this review we provide an overview of the role of DOT1L across the immune system and the implications of this role on health and disease. We begin by elucidating the general mechanisms of DOT1L-mediated histone methylation and its impact on gene expression within immune cells. Subsequently, we provide a detailed and comprehensive overview of recent studies that identify DOT1L as a crucial regulator of immune cell development, differentiation, and activation. Next, we discuss the potential mechanisms of DOT1L-mediated regulation of immune cell function and shed light on how DOT1L might be contributing to immune cell homeostasis and dysfunction. We then provide food for thought by highlighting some of the current obstacles and technical limitations precluding a more in-depth elucidation of DOT1L's role. Finally, we explore the potential therapeutic implications of targeting DOT1L in the context of immune-related diseases and discuss ongoing research efforts to this end. Overall, this review consolidates the current paradigm regarding DOT1L's role across the immune network and emphasises its critical role in governing the healthy immune system and its potential as a novel therapeutic target for immune-related diseases. A deeper understanding of DOT1L's immunomodulatory functions could pave the way for innovative therapeutic approaches which fine-tune the immune response to enhance or restore human health.

Citing Articles

Multiple phenotypes and epigenetic profiles in a three-generation family history with GATA2 deficiency.

Romero-Moya D, Pera J, Marin-Bejar O, Torralba-Sales E, Murillo-Sanjuan L, Diaz-de-Heredia C Leukemia. 2025; .

PMID: 39890964 DOI: 10.1038/s41375-025-02519-4.

Epigenetics of Skeletal Muscle Atrophy.

Du J, Wu Q, Bae E Int J Mol Sci. 2024; 25(15).

PMID: 39125931 PMC: 11312722. DOI: 10.3390/ijms25158362.

References

Godfrey L, Crump N, Thorne R, Lau I, Repapi E, Dimou D . DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation. Nat Commun. 2019; 10(1):2803. PMC: 6594956. DOI: 10.1038/s41467-019-10844-3. View

Vlaming H, McLean C, Korthout T, Alemdehy M, Hendriks S, Lancini C . Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L-dose dependency in HDAC1-deficient thymic lymphoma. EMBO J. 2019; 38(14):e101564. PMC: 6627229. DOI: 10.15252/embj.2019101564. View

Guenther M, Levine S, Boyer L, Jaenisch R, Young R . A chromatin landmark and transcription initiation at most promoters in human cells. Cell. 2007; 130(1):77-88. PMC: 3200295. DOI: 10.1016/j.cell.2007.05.042. View

Chen L, Deshpande A, Banka D, Bernt K, Dias S, Buske C . Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l. Leukemia. 2012; 27(4):813-22. PMC: 3932800. DOI: 10.1038/leu.2012.327. View

Sekiya T, Kashiwagi I, Inoue N, Morita R, Hori S, Waldmann H . The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat Commun. 2011; 2:269. PMC: 3104557. DOI: 10.1038/ncomms1272. View

Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield V . hDOT1L links histone methylation to leukemogenesis. Cell. 2005; 121(2):167-78. DOI: 10.1016/j.cell.2005.02.020. View

Deshpande A, Chen L, Fazio M, Sinha A, Bernt K, Banka D . Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l. Blood. 2013; 121(13):2533-41. PMC: 3612861. DOI: 10.1182/blood-2012-11-465120. View

Li G, Yu M, Lee W, Tsang M, Krishnan E, Weyand C . Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med. 2012; 18(10):1518-24. PMC: 3466346. DOI: 10.1038/nm.2963. View

Beguelin W, Popovic R, Teater M, Jiang Y, Bunting K, Rosen M . EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell. 2013; 23(5):677-92. PMC: 3681809. DOI: 10.1016/j.ccr.2013.04.011. View

10.

Kari V, Raul S, Henck J, Kitz J, Kramer F, Kosinsky R . The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness. Clin Epigenetics. 2019; 11(1):4. PMC: 6323691. DOI: 10.1186/s13148-018-0601-1. View

11.

Singer M, Kahana A, Wolf A, Meisinger L, Peterson S, Goggin C . Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae. Genetics. 1998; 150(2):613-32. PMC: 1460361. DOI: 10.1093/genetics/150.2.613. View

12.

Cattaneo P, Hayes M, Baumgarten N, Hecker D, Peruzzo S, Aslan G . DOT1L regulates chamber-specific transcriptional networks during cardiogenesis and mediates postnatal cell cycle withdrawal. Nat Commun. 2022; 13(1):7444. PMC: 9718823. DOI: 10.1038/s41467-022-35070-2. View

13.

Ruthenburg A, Allis C, Wysocka J . Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell. 2007; 25(1):15-30. DOI: 10.1016/j.molcel.2006.12.014. View

14.

Wu A, Zhi J, Tian T, Cihan A, Cevher M, Liu Z . DOT1L complex regulates transcriptional initiation in human erythroleukemic cells. Proc Natl Acad Sci U S A. 2021; 118(27). PMC: 8271641. DOI: 10.1073/pnas.2106148118. View

15.

Zhu B, Chen S, Wang H, Yin C, Han C, Peng C . The protective role of DOT1L in UV-induced melanomagenesis. Nat Commun. 2018; 9(1):259. PMC: 5772495. DOI: 10.1038/s41467-017-02687-7. View

16.

Good-Jacobson K, Chen Y, Voss A, Smyth G, Thomas T, Tarlinton D . Regulation of germinal center responses and B-cell memory by the chromatin modifier MOZ. Proc Natl Acad Sci U S A. 2014; 111(26):9585-90. PMC: 4084455. DOI: 10.1073/pnas.1402485111. View

17.

Zhou Z, Chen H, Xie R, Wang H, Li S, Xu Q . Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer. Mol Oncol. 2019; 13(4):873-893. PMC: 6441919. DOI: 10.1002/1878-0261.12443. View

18.

Kealy L, Di Pietro A, Hailes L, Scheer S, Dalit L, Groom J . The Histone Methyltransferase DOT1L Is Essential for Humoral Immune Responses. Cell Rep. 2020; 33(11):108504. DOI: 10.1016/j.celrep.2020.108504. View

19.

Worden E, Hoffmann N, Hicks C, Wolberger C . Mechanism of Cross-talk between H2B Ubiquitination and H3 Methylation by Dot1L. Cell. 2019; 176(6):1490-1501.e12. PMC: 6498860. DOI: 10.1016/j.cell.2019.02.002. View

20.

Feng Y, Yang Y, Ortega M, Copeland J, Zhang M, Jacob J . Early mammalian erythropoiesis requires the Dot1L methyltransferase. Blood. 2010; 116(22):4483-91. PMC: 3321834. DOI: 10.1182/blood-2010-03-276501. View